Latest / Public Health Review Morning Edition / 1042: Naloxone’s Impact: Inside New York’s Landmark Study on Lives Saved and Dollars Returned
Transcript
- 0:00This is Public HEALTH Review MORNING EDITION for Monday,
- 0:03December 15th, 2025. I'm John Sheehan with news from
- 0:07the Association of State and Territorial Health Officials.
- 0:10Today we take a look at the lives saved and the return on
- 0:13investment from New York State's harm reduction initiative to
- 0:16distribute. Naloxone the.
- 0:18Medication that can rapidly reduce an.
- 0:20Opioid overdose, my guest is. Doctor James McDonald, ASTO
- 0:24member and Commissioner of the New York State Department of.
- 0:26Health. When you think about this story
- 0:28it, it may be hard to put a value on a human life, but
- 0:30Health and Human Services has a value for a statistical life.
- 0:34It's a data point you can use. If you use the data point and
- 0:36then evaluate the whole program, that's what we did and that's
- 0:39how we show this cost effectiveness because quite
- 0:41frankly, for every dollar spent saving over $3219, that's really
- 0:47robust. Of course, there's more to the
- 0:49story than dollars. And cents.
- 0:51But as Doctor McDonald. Explains it's.
- 0:53Part of the narrative that officials can use when making
- 0:56the case for these harm reduction programs.
- 1:00Doctor James McDonald, welcome to the show.
- 1:02Thank you. Good to be with you today.
- 1:04So the. Study shows that naloxone saved
- 1:08more than 60. 500. Lives over 2 years in New York.
- 1:13Can you give us some context for these numbers and how other
- 1:16states should sort of think about them in their own harm
- 1:20reduction programs? You know, when you look at the
- 1:23New York data, what we showed in this study was this was really
- 1:25about naloxone administration. We have over 1400 opioid
- 1:31overdose prevention programs in New York State.
- 1:33So what we did is we looked at our over opioid overdose
- 1:37prevention programs. We just got the data from them
- 1:39and looked at how many administrations did you do and
- 1:43what was the outcome. And this is one of the things
- 1:44about this today that I think is really groundbreaking.
- 1:46It's outcome driven. What we show with the outcome is
- 1:49we saved a lot of lives over 6500.
- 1:52But we also showed is naloxone was a really important public
- 1:55health tool. It's not the only public health
- 1:57too and the overdose crisis, but it is a really important public
- 2:01health too, the cornerstone of harm reduction, if you will.
- 2:04And this is one of the first times that a state has sort of
- 2:06looked at the economic result of naloxone.
- 2:11And you mentioned sort of that it's outcome driven.
- 2:14Is that an example of how other states could sort of approach
- 2:17this kind of this kind of analysis?
- 2:20Yeah. So we looked at the
- 2:21administration. In other words, what we really
- 2:23wanted to know is it's not, it's not a bad thing to distribute
- 2:26naloxone. It's great to distribute
- 2:27naloxone. But what we really wanted to
- 2:29learn is what were the outcomes? In other words, was it cost
- 2:32effective? And that's what was different
- 2:34about the program. We didn't just add up the cost
- 2:35of naloxone, but of the entire opioid overdose prevention
- 2:40programs. And so you know, that's like $27
- 2:43million in New York State over a two year period.
- 2:45It's a, it's a substantial investment here, but we really
- 2:48saw very cost effective and it's really the first time we know of
- 2:53a state health department, really anyone doing the
- 2:55administration health economic evaluation.
- 2:58We used Health and Human Services Value for statistical
- 3:01Life to do the evaluation. And so really we did a robust
- 3:05evaluation to show that this isn't just a good idea, it's
- 3:08really cost effective. Sure.
- 3:11The amount of money versus the number of lives saved and the
- 3:15number of the the the dollar value on that.
- 3:19How should? Other state officials, how can
- 3:22they use these your results to sort of build their own case to
- 3:26policy makers when making the case for naloxone?
- 3:30Yeah. So part of why we did the
- 3:32evaluations, just recognizing more and more in public health,
- 3:35people want to see return on investment.
- 3:37They really want to understand, you know, you're doing an
- 3:40activity, it leads to productivity, but what's the
- 3:42positive outcome? And then is the return on
- 3:44investment. And that's how I define work at
- 3:47the New York State Department of Health, by the way, is it's an
- 3:49activity, it leads to productivity, leads to a
- 3:51positive outcome, and then what's the return on investment?
- 3:55This is one of those things where when you think about
- 3:56public health of the future, we need to talk this language a
- 4:00little more clearly to people like in the in the return
- 4:02investment. This is substantial.
- 4:04You know, you've heard the expression ounce of prevention
- 4:06worth a pound of cure. Well, this is really a pound of
- 4:11prevention worth a ton and a half of cure because the the
- 4:14cost, you know when we look at return investment, we're talking
- 4:17about for every dollar we spent, we saved over $3200.
- 4:22You know that $1.00 to over $3200, that's a huge return
- 4:27investment, really very little like that.
- 4:29Yeah, that's very stark. When you put it like that, the
- 4:32case sort of makes itself. You're saving over $3000 per
- 4:37dollar spent. Yeah, it it's really a good
- 4:40example of just when you do the health economic evaluation and
- 4:43fortunately we have people here who could do that.
- 4:45You see the cost effectiveness and I'm not sure every state
- 4:47needs to do the study. We did it.
- 4:49I think it's scalable to other states.
- 4:51I think it's extrapolatable to other states.
- 4:54And, and I think it really underscores the importance of
- 4:56not just naloxone distribution, but training people to use
- 5:00naloxone. I think that's really in a
- 5:01critical part of our program is we train people recognize when
- 5:05to use naloxone and how to use it and then how to give us the
- 5:08data so we can have the outcome. Are there other lessons that you
- 5:11learned through through the program or through the analysis
- 5:15that you think would be transferable to other states?
- 5:18You know, this is not the only solution, right?
- 5:21Like, we need to make sure we prescribe opioids responsibly as
- 5:24healthcare providers. We need to make sure there's
- 5:27easy access to treatment. We also make sure people have
- 5:29the social service supports they need as they go through the
- 5:32chronic disease of, you know, opioid addiction.
- 5:35I think Reddit underscores though, is that harm reduction
- 5:38really important part of our comprehensive plan.
- 5:41Naloxone is really the cornerstone to that treatment.
- 5:44Yeah. And as overdoses continue and as
- 5:48overdose patterns change, what would next steps look like for
- 5:53this program or for for how naloxone gets distributed in the
- 5:57future? You know, when we look at New
- 5:59York data, we still have over 4000 overdose deaths per year in
- 6:04New York. So we still have work to do.
- 6:06When I look at our suitors data, 70% of fatal overdoses in New
- 6:10York State occur in a home or an apartment.
- 6:14You know, so it really underscores the importance of
- 6:16getting the locks on into people's hands.
- 6:18But the thing we also noticed from our suitors data is for
- 6:21whatever reason, about 1/3 of the persons who experienced A
- 6:24fatal drug overdose, there was a bystander nearby.
- 6:27So it's really important for the bystander to be trained in how
- 6:30to use naloxone. Those are next steps as well.
- 6:33And I think it also just really underscores this is actually a
- 6:38controllable problem. You know, when in New York, we
- 6:40talked about this somewhat seriously.
- 6:41We're trying to achieve an overdose free generation.
- 6:45You know, there's not one tool to solve it.
- 6:46But this is the direction we're hoping to head in in New York
- 6:49State. Yeah, and as you say, it's not
- 6:52the only tool, but it's a very effective 1, so keep using it.
- 6:56It's a very effective tool, and I think it underscores, when I
- 6:59look at the future of public health more and more what I see
- 7:02is being able to talk to politicians and others about how
- 7:07do you show return on investment.
- 7:08This is part of why we did this study, because I think return on
- 7:11investment, it's close to a universal language.
- 7:13People understand that. Yeah, it's it's hard to argue
- 7:17with with the bottom line as they.
- 7:19Say indeed. James McDonald is an ASTO member
- 7:24and. Commissioner of the New York.
- 7:25State. Department.
- 7:26Of health. Public health can't go it alone.
- 7:30In a time of shrinking budgets and growing community needs,
- 7:33strong cross sector partnerships aren't just helpful, they're
- 7:36essential. Asto's latest blog breaks down
- 7:39how collaborations between health departments, nonprofits,
- 7:42grassroots groups and community health workers are helping
- 7:46communities tackle the root causes of poor health, rebuild
- 7:49trust, and do more with less. Discover how working upstream
- 7:53together is the key to achieving a healthier, more equitable
- 7:56future. Read the full story at asto.org.
- 8:00ASTO welcomes new member Larry Johnson, director of the Iowa
- 8:04Department of Health and Human Services.
- 8:06Prior to his appointment, Director Johnson LED Iowa's
- 8:08Department of Inspections, Appeals and Licensing and also
- 8:12held positions as the state public defender and legal
- 8:14counsel to the governor. Learn more about Director
- 8:17Johnson in the show notes. Join Manisha.
- 8:20Juthani, MD. Commissioner, Connecticut.
- 8:22Department of Public Health and ASTO President, and John
- 8:26Auerbach, MBA, senior Vice President for Public Health,
- 8:28ICF, for a webinar that examines how clear, purposeful leadership
- 8:33strengthens both internal and external trust.
- 8:36Through insights and reflection, we will examine how leaders
- 8:39embody steadiness amid uncertainty, set a sustainable
- 8:42pace, and provide calm direction that builds trust and drives
- 8:46performance. This conversation aims to
- 8:48inspire participants to recognize their composure and
- 8:51capacity not as a personal indulgence, but as a fundamental
- 8:55leadership function that shapes the overall tone, focus and
- 8:58confidence of their organizations.
- 9:01This has been Public Health Review Morning Edition.
- 9:03I'm John Sheehan for the Association of State and
- 9:05Territorial Health Officials.